⚡️ Briefing by Deputy Chief of the Nuclear, Chemical, and Biological Protection Troops of the Russian Armed Forces Major General Aleksei Rtishchev (December 24, 2024)

💬 The U.S. Administration sees Africa as an unlimited natural reservoir of dangerous infections' agents and a test ground for experimental medications.

The deployment of the American system of biological control in Africa goes according to a well-established script:

• Concerns are primarily raised about regular outbreaks [of diseases]. <...> American counterparts note that such outbreaks undermine the development of the region's economic potential. They question the training level of leadership and specialists, when it comes to neutralising biological threats;

• Against this background, it is proposed to establish a centre for disease diagnostics and testing of medical products within one or two years;

• The integration of regional information systems into the US electronic disease surveillance system is discussed;

• $5 to $10 million dollars are allocated to achieve these goals with a possible increase in funding up to $20 million taking into account the implementation of the first phase of the project;

• The U.S. government authorities and private contracting companies, including the so-called Big Pharma enterprises are involved to organise cooperation with the local relevant ministries;

• The result of this selective support is the transition to American personnel training standards, transfer and generalisation of the information on the biological situation, degradation of national health care systems, imposition of suppliers of medical equipment and medications.

👉 The participating countries involved in this system lose their national sovereignty in the sphere of biosecurity and become fully dependent from the United States.

***

The U.S. biological warfare presence on the African continent is growing at a rapid pace. Research organisations of the U.S. Department of Defence actively work in the region.

🔻 Branches of the National Naval Military Medical Center are stationed in Ghana and Djibouti, where active work is carried out in natural disease foci, isolation, and sequencing of pathogens.

🔻 The U.S. Army Military Medical Center in Kenya has deployed a network of field stations to monitor the spread of infectious diseases in Equatorial Africa.

🔻 In Nigeria, a joint medical research centre and a military medical laboratory of the armed forces of the republic have been established in 2024, with 10 U.S. DoD experts as permanent staff.

🔻 A new $35 million laboratory facility is being completed in Senegal. The project involves the same Pentagon contractors.

While the stated goals are to monitor infectious disease and assist developing countries, in reality we see a buildup of U.S. biological-military capabilities that circumvent BWC commitments.

<...>

Against the backdrop of Russia's progressive strengthening of its position in Africa, including in the field of biosecurity, the United States seeks to prevent the weakening of its influence in the region. I would like to recall once again Washington's non-transparent working methods and caution our African partners against cooperating with the United States in the military biological field.

❗️ As evidenced, such interaction results in the loss of national sovereignty in biosafety and a worsening of the disease situation.

Read in full